Product Information

DEXLANSOPRAZOLE DR 60 MG CAP is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $3.7588 per EA under NDC 00378208693. Its NADAC has been published 140 times since Mar 13, 2024.

FDA first approved this application on Jan 19, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DEXLANSOPRAZOLE DR 60 MG CAP

dexlansoprazole
$3.7588per EA

Strength

60 mg/1

NDC

00378208693

Classification

Generic

Dosage Form

CAPSULE, DELAYED RELEASE PELLETS

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA205205

FDA Approved

1/19/2024

TE Code

AB

On Market Since

1/22/2024

Pharmacological Classes

Proton Pump Inhibitor
Proton Pump Inhibitors

Price Statistics

The NADAC for DEXLANSOPRAZOLE DR 60 MG CAP has been published 140 times since Mar 13, 2024, and over the history we have for it it has declined 41.6%. The table below summarizes its recorded NADAC range and movement.

Current price$3.7588 per EA
All-time high$6.4693 (Apr 10, 2024)
All-time low$3.6568 (Aug 19, 2026)
52-week high$4.3996
52-week low$3.6568
Median price$4.5805
Average price$4.6312
Largest weekly change-16.5% (Nov 20, 2024)
Weeks tracked140
Tracking sinceMar 13, 2024

Price History

1W

0.0%

1M

+1.4%

3M

+2.1%

6M

-7.5%

1Y

-16.6%

3Y

N/A

5Y

N/A

All

-41.6%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DEXLANSOPRAZOLE DR 60 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for DEXLANSOPRAZOLE DR 60 MG CAP, manufactured by Mylan Pharmaceuticals Inc., is $3.7588 per EA (NDC 00378208693), effective Nov 11, 2026.

How has the price of DEXLANSOPRAZOLE DR 60 MG CAP changed over time?

Over the history we have for it, the NADAC for DEXLANSOPRAZOLE DR 60 MG CAP has declined 41.6%. It has been tracked across 140 weekly CMS publications since Mar 13, 2024.

What are the highest and lowest recorded NADAC prices for DEXLANSOPRAZOLE DR 60 MG CAP?

Since Mar 13, 2024, the NADAC for DEXLANSOPRAZOLE DR 60 MG CAP has ranged from a low of $3.6568 (Aug 19, 2026) to a high of $6.4693 (Apr 10, 2024), with a median of $4.5805 per EA.

Are there cheaper alternatives to DEXLANSOPRAZOLE DR 60 MG CAP?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DEXLANSOPRAZOLE DR 60 MG CAP in a comparable dosage form, but none are currently priced below it.

Who manufactures DEXLANSOPRAZOLE DR 60 MG CAP?

DEXLANSOPRAZOLE DR 60 MG CAP (NDC 00378208693) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.